Rite Aid and Heritage Provider Network last month announced a new agreement to bring the Rite Aid Health Alliance program to HPN's chronic and polychronic patients in Southern California.
The Food and Drug Administration on Friday will publish the fiscal year 2015 generic drug user fee rates as required under the Food Drug and Cosmetic Act as amended by the Generic Drug User Fee Amendments of 2012.
Teva Pharmaceuticals on Thursday announced results for second-quarter 2014, which included revenues of $5 billion, an increase of 2% compared with the same period last year.
CVS/pharmacy is the first pharmacy in the nation to earn the new Community Pharmacy accreditation from URAC.
McKesson on Thursday reported revenues of $44.1 billion for the first quarter ended June 30, up 37%.
Pfizer on Wednesday announced that it has entered into a definitive agreement to acquire Baxter International’s portfolio of marketed vaccines for $635 million.
Perrigo on Wednesday announced that it has filed an abbreviated new drug application with the Food and Drug Administration for desoximetasone topical spray 0.25%. The company also has notified Taro Pharmaceuticals U.S.A., the owner of the reference listed drug, of the filing.
GSK announced that Tanzeum (albiglutide), a once-weekly, prescription injectable treatment for Type 2 diabetes in adults, is now available in pharmacies throughout the United States.
The use of FDA drug safety programs to prevent generic competition is costing the American health care system and patients $5.4 billion in annual pharmaceutical spending.
The Food and Drug Administration may have more generic drug applications than it does personnel to process them, according to a Wall Street Journal report published Tuesday.